SEC Form 4 · accession 0000899243-16-020579
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nezam H. Afdhal
Officer — Chief Medical Officer
Period of report
May 19, 2016
Accepted (ET)
May 20, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.97 | May 19, 2016 | A | 5,000 | A | — | May 18, 2026 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1This option was granted on May 19, 2016, with 25% of the shares subject to the option vesting on January 1, 2017 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.